Synthego, a genome engineering company, has broken ground on a 20,000-sq.-ft. manufacturing facility designed to accelerate translational and clinical research development timelines for cell and gene therapies to as little as a year. The next-generation good manufacturing practices (GMP) factory, an expansion of the Halo Platform, will enable Synthego to significantly expand production of its precision gene editing tools to support a broad panel of nucleases, and meet the needs of biopharma cust...